European patent office restores breast cancer gene patent
November 20th, 2008 in Medicine & Health / GeneticsThe European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.
Content from AFP expires 1 month after original publication date. For more information about AFP, please visit www.afp.com .